InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Blutt Mitchell J Md, 董事. Director active across 2 companies, notably Consonance-HFW Acquisition Corp.. Aggregated, 4 filings have been logged. Split: 0 buy · 1 sell. Activity tracked since 4 September 2020. The latest transaction was disclosed on 4 September 2020 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Blutt Mitchell J Md
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
1,748,750 股Common StockSEC:0000899243-22-038571:0
500,000 股Class A Ordinary SharesSEC:0000899243-21-033025:0
3,593,750 股@ US$0.007100.0% 占其流量Class B Ordinary SharesSEC:0000899243-21-019995:0
24,000 股Class A Ordinary SharesSEC:0000899243-21-019983:0
4 条申报中的 4 条
About Blutt Mitchell J Md
Mitchell J. Blutt, MD, is a Director of Consonance-HFW Acquisition Corp. and Surrozen, Inc./DE. He brings his medical and strategic expertise to the board, contributing to the direction of the companies.
